Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements.
University of Iowa researchers identified a connection between a routine treatment for Parkinson’s disease and a tendency for some patients to develop increased impulsivity located around a specific ...
DEAR DR. ROACH: I’m a 65-year-old and otherwise healthy male. After spending the past five years believing that my trembling hands were the result of essential tremor, a second DaT (dopamine ...
Hosted on MSN
New weekly injectable drug could transform the lives of people living with Parkinson’s disease
A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...
Meanwhile, beta blocker medications tend to reduce REM sleep, which is when most dreaming occurs, but research has found that ...
After being rejected twice before, AbbVie’s latest Parkinson’s drug finally has been approved by the U.S. Food & Drug Administration. Findings from clinical studies of the drug, called Vyalev, showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback